Company Filing History:
Years Active: 2010-2012
Title: Hiroshi Tsuruta: Innovator in Pharmaceutical Compounds
Introduction
Hiroshi Tsuruta is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on diketohydrazine derivative compounds. His inventions have the potential to address various medical conditions, showcasing his dedication to improving healthcare.
Latest Patents
Hiroshi Tsuruta holds 2 patents related to diketohydrazine derivative compounds and their applications in medicine. His latest patent describes a diketohydrazine derivative of formula (I) and a pharmaceutically acceptable salt thereof. The compound exhibits inhibitory activity against cysteine protease, making it useful for treating inflammatory diseases, immune diseases, ischemic diseases, respiratory diseases, circulatory diseases, blood diseases, neuronal diseases, hepatic or biliary diseases, osseous or articular diseases, and metabolic diseases. Additionally, the compound has inhibitory activity against elastase, which is beneficial for the treatment of chronic obstructive pulmonary disease (COPD).
Career Highlights
Hiroshi Tsuruta is currently associated with Ono Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions that address critical health issues.
Collaborations
Throughout his career, Hiroshi has collaborated with esteemed colleagues such as Akira Hatayama and Yasuo Ochi. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical compounds.
Conclusion
Hiroshi Tsuruta's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to advancing medical science. His work not only addresses significant health challenges but also exemplifies the impact of dedicated inventors in the healthcare industry.